Tiger BioSciences Expands Wound Care Solutions with HealPACK Acquisition
Tiger BioSciences Expands Its Wound Care Offerings
In a strategic move designed to enhance patient care, Tiger BioSciences has announced the acquisition of Encore Surgical's innovative HealPACK solutions through its wholly owned subsidiary, Tiger Wound Care. This acquisition marks a pivotal expansion of Tiger's portfolio in the healthcare industry, particularly in the realm of post-operative wound care.
The Innovation Behind HealPACK
The HealPACK was developed by Novo Health Care Services and Encore Surgical Supplies as an advanced surgical dressing solution aimed at amplifying the healing process after surgery. What sets HealPACK apart is not just its premium-quality surgical dressings but also its convenience of delivery directly to the patient's doorstep. This innovation facilitates treatments in the comfort of the home, bridging a significant gap in postoperative care.
Physicians across the nation trust HealPACK products for their quality and effectiveness. The accompanying HealPACK app simplifies the prescription and insurance confirmation processes, making it easier for healthcare providers to manage patient orders while ensuring compliance with insurance requirements. Additionally, the app is designed to help with the documentation necessary for securing reimbursements for the dressings.
Streamlining Patient Care and Compliance
Each order prescribed by physicians is tailored to the specific needs of the patient, ensuring that healing materials are ideally suited for every case. This not only diminishes the risk of interrupted treatment but significantly boosts patient adherence to wound care regimens. The result is a more efficient healthcare delivery model that saves both time and resources for medical practitioners.
Miro Kesic, CEO of Encore, highlights the rapid success of the HealPACK since its introduction: “Our goal has always been to empower physicians in delivering essential postoperative therapies. The synergy between our innovative technology and timely execution has propelled Encore to the forefront of this market.”
Neall French, Encore's President, emphasizes the importance of continued innovation in wound care, which will be greatly augmented through this alliance with Tiger BioSciences. He notes: “Aligning with Tiger BioSciences is an exciting next step. Their leadership and comprehensive portfolio will enhance our capabilities and ultimately benefit patients.”
Tiger BioSciences' Vision for the Future
For Tiger BioSciences, the acquisition of HealPACK complements their existing wound care offerings and positions them as a leader in the industry. Oliver Burckhardt, Co-CEO of Tiger BioSciences, said, “HealPACK and its innovative HealAPP represent a wonderful addition to our product lineup. We aim to leverage our vast customer network across orthopedics, podiatry, and plastic surgery to maximize the benefits of this acquisition.”
Tiger BioSciences is renowned for its commitment to advancing regenerative medicine. The company focuses on cell and tissue technologies that shape the future of medical treatment pathways. Their mission incorporates comprehensive efforts from concept to clinical application, ensuring that developments in tissue engineering and related technologies are at the core of their services.
Conclusion
The integration of Encore Surgical’s HealPACK marks a significant milestone for Tiger BioSciences. This acquisition reinforces their resolve to deliver exceptional clinical outcomes while enhancing the overall experience for patients and healthcare providers alike. With a focus on innovative solutions and comprehensive support, Tiger BioSciences is firmly securing its position as a leader in modern wound care management.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.